SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

43.02

1037.7

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.06

Back

simplex papers ltd

Axis Bank consolidated net profit rises 39.38% in the September 2026 quarter

Oct 17,2026

Net profit of Axis Bank rose 39.38% to Rs 7704.67 crore in the quarter ended September 2026 as against Rs 5527.85 crore during the previous quarter ended September 2025. Total Operating Income rose 17.88% to Rs 38087.48 crore in the quarter ended September 2026 as against Rs 32309.77 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Total Operating Income	38087.48	32309.77	18
OPM %	64.84	55.73	-
PBDT	10351.65	7495.94	38
PBT	10351.65	7495.94	38
NP	7704.67	5527.85	39

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)